Literature DB >> 23178487

Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.

K Ogami1, N Hosoda1, Y Funakoshi1, S Hoshino1.   

Abstract

The regulation of mRNA deadenylation constitutes a pivotal mechanism of the post-transcriptional control of gene expression. Here we show that the antiproliferative protein Tob, a component of the Caf1-Ccr4 deadenylase complex, is involved in regulating the expression of the proto-oncogene c-myc. The c-myc mRNA contains cis elements (CPEs) in its 3'-untranslated region (3'-UTR), which are recognized by the cytoplasmic polyadenylation element-binding protein (CPEB). CPEB recruits Caf1 deadenylase through interaction with Tob to form a ternary complex, CPEB-Tob-Caf1, and negatively regulates the expression of c-myc by accelerating the deadenylation and decay of its mRNA. In quiescent cells, c-myc mRNA is destabilized by the trans-acting complex (CPEB-Tob-Caf1), while in cells stimulated by the serum, both Tob and Caf1 are released from CPEB, and c-Myc expression is induced early after stimulation by the stabilization of its mRNA as an 'immediate-early gene'. Collectively, these results indicate that Tob is a key factor in the regulation of c-myc gene expression, which is essential for cell growth. Thus, Tob appears to function in the control of cell growth at least, in part, by regulating the expression of c-myc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178487     DOI: 10.1038/onc.2012.548

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

Review 1.  MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.

Authors:  E Hessmann; G Schneider; V Ellenrieder; J T Siveke
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

2.  Dynamic Control of Dendritic mRNA Expression by CNOT7 Regulates Synaptic Efficacy and Higher Cognitive Function.

Authors:  Rhonda L McFleder; Fernanda Mansur; Joel D Richter
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

3.  Direct evidence that Ataxin-2 is a translational activator mediating cytoplasmic polyadenylation.

Authors:  Hiroto Inagaki; Nao Hosoda; Hitomi Tsuiji; Shin-Ichi Hoshino
Journal:  J Biol Chem       Date:  2020-09-28       Impact factor: 5.157

4.  Phosphorylation of TOB1 at T172 and S320 is critical for gastric cancer proliferation and progression.

Authors:  Dong Wang; He Song; Tie Zhao; Mengxi Wang; Yanhong Wang; Lina Yu; Ping Wang; Jingcui Yu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 5.  Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.

Authors:  Hun Seok Lee; Juthika Kundu; Ryong Nam Kim; Young Kee Shin
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

Review 6.  Deadenylation of mRNA by the CCR4-NOT complex in Drosophila: molecular and developmental aspects.

Authors:  Claudia Temme; Martine Simonelig; Elmar Wahle
Journal:  Front Genet       Date:  2014-05-26       Impact factor: 4.599

7.  The STAR protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRNAs.

Authors:  Ryota Yamagishi; Takeshi Tsusaka; Hiroko Mitsunaga; Takaharu Maehata; Shin-ichi Hoshino
Journal:  Nucleic Acids Res       Date:  2016-02-29       Impact factor: 16.971

Review 8.  Multifunctional roles of the mammalian CCR4-NOT complex in physiological phenomena.

Authors:  Yo-Taro Shirai; Toru Suzuki; Masahiro Morita; Akinori Takahashi; Tadashi Yamamoto
Journal:  Front Genet       Date:  2014-08-21       Impact factor: 4.599

9.  Genomic Analyses of Sperm Fate Regulator Targets Reveal a Common Set of Oogenic mRNAs in Caenorhabditis elegans.

Authors:  Daniel C Noble; Scott T Aoki; Marco A Ortiz; Kyung Won Kim; Jamie M Verheyden; Judith Kimble
Journal:  Genetics       Date:  2015-11-12       Impact factor: 4.562

10.  Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7.

Authors:  Farhoud Faraji; Ying Hu; Howard H Yang; Maxwell P Lee; G Sebastian Winkler; Markus Hafner; Kent W Hunter
Journal:  PLoS Genet       Date:  2016-01-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.